Oric Pharmaceuticals (NASDAQ:ORIC) reported updated Phase 1b data for enozertinib in previously untreated patients with advanced non-small cell lung cancer (NSCLC) carrying atypical EGFR mutations, highlighting systemic and intracranial responses in a cohort with a high prevalence of baseline brain metastases. The company said the results, presented at the European Society for Medical Oncology meeting, […]

Zai Lab (NASDAQ:ZLAB) presented early-stage data at the 2026 European Society for Medical Oncology meeting for zoci, its DLL3-targeted antibody-drug conjugate, in combination with atezolizumab, with or without carboplatin, for first-line extensive-stage small cell lung cancer. Rafael Amado, Zai Lab’s president and head of global research and development, said the results support the company’s plans […]

Zai Lab (NASDAQ:ZLAB) presented early-stage data at the 2026 European Society for Medical Oncology meeting for zoci, its DLL3-targeted antibody-drug conjugate, in combination with atezolizumab, with or without carboplatin, for first-line extensive-stage small cell lung cancer. Rafael Amado, Zai Lab’s president and head of global research and development, said the results support the company’s plans […]